Eculizumab Use in the Postpartum Period for the Treatment of Pregnancy Associated Atypical Hemolytic Uremic Syndrome: A Case Series
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 18 Jul 2018
Price : $35 *
At a glance
- Drugs Eculizumab (Primary)
- Indications Haemolytic uraemic syndrome
- Focus Therapeutic Use
- 06 Jul 2018 Planned End Date changed from 15 Oct 2018 to 15 Dec 2018.
- 06 Jul 2018 Planned primary completion date changed from 15 Jul 2018 to 15 Sep 2018.
- 05 Jul 2018 New trial record